Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Translational Autoimmunity|March 6, 2024
Presentation and progression of MPO-ANCA interstitial lung diseaseLorenzo Salvati, Boaz Palterer, Elena Lazzeri, et al.Frontiers in Pharmacology|September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Donato Rigante, Piero Ruscitti, et al.Frontiers in Pharmacology|April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment ResponseAntonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.Frontiers in Medicine|March 11, 2020
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory OutcomesAntonio Vitale, Giulio Cavalli, Piero Ruscitti, et al.Clinical Rheumatology|May 18, 2018
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyJurgen Sota, Antonio Vitale, Antonella Insalaco, et al.Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.Pageof 3